Authors:
LEDERMAN S
SULLIVAN G
BENIMETSKAYA L
LOWY I
LAND K
KHALED Z
CLEARY AM
YAKUBOV L
STEIN CA
Citation: S. Lederman et al., POLYDEOXYGUANINE MOTIFS IN A 12-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE AUGMENT BINDING TO THE V3LOOP OF HIV-I GP-120 AND POTENCY OF HIV-1 INHIBITION IN DEPENDENTLY OF G-TETRAD FORMATION (VOL 6, PG 286, 1996), ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(2), 1997, pp. 131-131
Authors:
CHEMLA K
MINARD P
RASMUSSEN A
FAYETSCRIBE S
BRIOIST P
LELONG B
PESTRE D
BOUDIA S
LOWY I
JAMI C
PETITJEAN P
Citation: K. Chemla et al., DISCUSSION ON SCIENCE AND SOCIABILITY IN 18TH-CENTURY EUROPE, PART 2, Revue d'histoire moderne et contemporaine, 44, 1997, pp. 68-71
Citation: I. Lowy, LIVING IN A TECHNOLOGICAL CULTURE - HUMAN TOOLS AND HUMAN-VALUES - TILES,M, OBERDIEK,H, Studies in history and philosophy of science, 28(3), 1997, pp. 533-543
Citation: I. Lowy, ALTERNATIVE MODERNITY - THE TECHNICAL TURN IN PHILOSOPHY AND SOCIAL-THEORY - FEENBERG,A, Studies in history and philosophy of science, 28(3), 1997, pp. 533-543
Citation: I. Lowy, EPIDEMIOLOGY, IMMUNOLOGY, AND YELLOW-FEVER - THE ROCKEFELLER-FOUNDATION IN BRAZIL, 1923-1939, Journal of the history of biology, 30(3), 1997, pp. 397-417
Authors:
MAK J
KHORCHID A
CAO Q
HUANG Y
LOWY I
PARNIAK MA
PRASAD VR
WAINBERG MA
KLEIMAN L
Citation: J. Mak et al., EFFECTS OF MUTATIONS IN PR160(GAG-POL) UPON TRNA(LYS3) AND PR160(GAG-POL) INCORPORATION INTO HIV-1, Journal of Molecular Biology, 265(4), 1997, pp. 419-431
Authors:
LEDERMAN S
SULLIVAN G
BENIMETSKAYA L
LOWY I
LAND K
KHALED Z
CLEARY AM
YAKUBOV L
STEIN CA
Citation: S. Lederman et al., POLYDEOXYGUANINE MOTIFS IN A 12-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE AUGMENT BINDING TO THE V3 LOOP OF HIV-1 GP120 AND POTENCY OF HIV-1 INHIBITION INDEPENDENTLY OF G-TETRAD FORMATION, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 6(4), 1996, pp. 281-289
Citation: K. Saha et al., HERPESVIRUS SAIMIRI-TRANSFORMED HUMAN CD4(-CELLS CAN PROVIDE POLYCLONAL B-CELL HELP VIA THE CD40 LIGAND AS WELL AS THE TNF-ALPHA PATHWAY AND THROUGH RELEASE OF LYMPHOKINES() T), The Journal of immunology, 157(9), 1996, pp. 3876-3885
Citation: I. Lowy, NOTHING MORE TO BE DONE - PALLIATIVE CARE VERSUS EXPERIMENTAL-THERAPYIN ADVANCED CANCER, Science in context, 8(1), 1995, pp. 209-229
Authors:
CARUSO M
SALOMON B
ZHANG S
BRISSON E
CLAVEL F
LOWY I
KLATZMANN D
Citation: M. Caruso et al., EXPRESSION OF A TAT-INDUCIBLE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE PROTECTS ACYCLOVIR-TREATED CD4 CELLS FROM HIV-1 SPREAD BY CONDITIONAL SUICIDE AND INHIBITION OF REVERSE TRANSCRIPTION, Virology, 206(1), 1995, pp. 495-503
Authors:
REICIN AS
PAIK S
BERKOWITZ RD
LUBAN J
LOWY I
GOFF SP
Citation: As. Reicin et al., LINKER INSERTION MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1GAG GENE - EFFECTS ON VIRION PARTICLE ASSEMBLY, RELEASE, AND INFECTIVITY, Journal of virology, 69(2), 1995, pp. 642-650
Citation: I. Lowy et al., CELLULAR THYMIDINE KINASE-ACTIVITY IS REQUIRED FOR THE INHIBITION OF HIV-1 REPLICATION BY AZT IN LYMPHOCYTES, Virology, 200(1), 1994, pp. 271-275
Citation: I. Lowy, ON HYBRIDIZATIONS, NETWORKS AND NEW DISCIPLINES - THE PASTEUR INSTITUTE AND THE DEVELOPMENT OF MICROBIOLOGY IN FRANCE, Studies in history and philosophy of science, 25(5), 1994, pp. 655-688
Citation: I. Lowy, EXPERIMENTAL SYSTEMS AND CLINICAL PRACTICES - TUMOR IMMUNOLOGY AND CANCER-IMMUNOTHERAPY, 1895-1980, Journal of the history of biology, 27(3), 1994, pp. 403-435